Frentizole
Aβ-ABAD inhibitor
Aβ-ABAD inhibitor
Discription | Frentizole, an FDA-approved immunosuppressive drug, is a novel inhibitor of the Aβ-ABAD interaction. |
|||||
---|---|---|---|---|---|---|
Cell Research |
|
目录号 | A21335 |
---|---|
分子式 | C15H13N3O2S |
分子量 | 299.35 |
CAS号 | 26130-02-9 |
SMILES | O=C(NC1=CC=CC=C1)NC2=NC3=CC=C(OC)C=C3S2 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 58 mg/mL (193.75 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 33.41 mL | 167.03 mL | 334.06 mL |
0.5 mM | 6.68 mL | 33.41 mL | 66.81 mL |
1 mM | 3.34 mL | 16.7 mL | 33.41 mL |
5 mM | 0.67 mL | 3.34 mL | 6.68 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2